35th National Conference of the Italian Group for the Study of Neuromorphology, November 28-29, 2025
Vol. 69 No. s3 (2025): Proceedings of the 35th National Conference of the Italian Group for the Study of Neuromorphology

OVEREXPRESSION OF ANOSMIN-1 ALTERS THE MYELINATION PATTERN AND THE MORPHOLOGY OF AXONAL COMPONENTS IN CEREBELLAR PURKINJE CELLS

Fieromonte A1, Lorenzati M1, Staffa A2, Bribian A2, Barderas MG3, Aguilar J4, De Castro F2 and Buffo A1 | 1Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Department of Neuroscience ita Levi, Montalcini, Turin, Italy; 2Instituto Cajal-CSIC, Grupo de Neurobiologia del Desarrollo-GNDe, Madrid, Spain; 3Servicio de Salud de Castilla- La Mancha-SESCAM, Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, Toledo, Spain; 4Servicio de Salud de Castilla-La Mancha-SESCAM, Experimental Neurophysiology Group, Hospital Nacional de Paraplejicos, Toledo, Spain

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 12 December 2025
111
Views
0
Downloads

Authors

Anosmin-1 (A1) is an extracellular matrix glycoprotein that regulates FGF, Wnt, BMP, and VEGF signaling pathways during nervous system development, and is widely expressed throughout the central nervous system, including the cerebellum. Mutations in the ANOS1 gene (formerly KAL1), which encodes A1, cause Kallmann syndrome (KS), a rare congenital disorder characterized by hypogonadotropic hypogonadism and anosmia. Given that the A1-overexpressing mouse model exhibits ataxia-like motor deficits, we hypothesized that these abnormalities might result from cerebellar dysfunction. Alterations in myelin formation and in the structural components of axons are major contributors to both the generation and conduction velocity of action potentials and may represent a key mechanism underlying the motor impairments observed in A1-overexpressing mice. To investigate this possibility, we examined the maturation dynamics of the axon initial segment (AIS) and the overall myelination pattern. Immunostaining of Ankyrin-g, a reliable marker of the AIS, revealed distinct morphological modifications in Purkinje cell axons of A1-overexpressing mice. Specifically, AISs in mutant mice are significantly longer and located further away from the soma compared to wild-type (WT) controls at adult stages. To assess potential structural modifications in the nodal and paranodal regions, we measured the length of nodes of Ranvier and found that, at postnatal day 60, mutant mice displayed longer nodes compared to WT. Moreover, during development, A1-overexpressing mice exhibited an altered timeline of myelination with evidence that the deposition occurs earlier compared to WT. Yet, in the mutants myelination reaches normal levels at adult stages. These data indicate that A1 regulates both the timing of myelin deposition and the structural organization of axonal domains, thereby participating in the neuromorphological shaping of Purkinje cell axons essential for efficient signal transmission.

Downloads

Download data is not yet available.

Citations

No refs.

How to Cite



1.
OVEREXPRESSION OF ANOSMIN-1 ALTERS THE MYELINATION PATTERN AND THE MORPHOLOGY OF AXONAL COMPONENTS IN CEREBELLAR PURKINJE CELLS: Fieromonte A1, Lorenzati M1, Staffa A2, Bribian A2, Barderas MG3, Aguilar J4, De Castro F2 and Buffo A1 | 1Neuroscience Institute Cavalieri Ottolenghi (NICO), University of Turin, Department of Neuroscience ita Levi, Montalcini, Turin, Italy; 2Instituto Cajal-CSIC, Grupo de Neurobiologia del Desarrollo-GNDe, Madrid, Spain; 3Servicio de Salud de Castilla- La Mancha-SESCAM, Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos, Toledo, Spain; 4Servicio de Salud de Castilla-La Mancha-SESCAM, Experimental Neurophysiology Group, Hospital Nacional de Paraplejicos, Toledo, Spain. Eur J Histochem [Internet]. 2025 Dec. 12 [cited 2026 Jan. 19];69(s3). Available from: https://www.ejh.it/ejh/article/view/4490